98 related articles for article (PubMed ID: 10931010)
1. SYNDECAN-1 (CD138) expression in human non-Hodgkin's lymphomas.
Sutcliffe M; Oscier D; Wright DH
Br J Haematol; 2000 Jul; 110(1):239-40. PubMed ID: 10931010
[No Abstract] [Full Text] [Related]
2. Expression of BCL-6 protein and CD138/syndecan-1 as B-cell markers in Hodgkin's disease.
Carbone A; Gloghini A; Gaidano G
Int J Biol Markers; 1999; 14(3):144-8. PubMed ID: 10569135
[No Abstract] [Full Text] [Related]
3. Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas.
Sebestyén A; Berczi L; Mihalik R; Paku S; Matolcsy A; Kopper L
Br J Haematol; 1999 Feb; 104(2):412-9. PubMed ID: 10050727
[TBL] [Abstract][Full Text] [Related]
4. The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens.
Costes V; Magen V; Legouffe E; Durand L; Baldet P; Rossi JF; Klein B; Brochier J
Hum Pathol; 1999 Dec; 30(12):1405-11. PubMed ID: 10667416
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.
Carbone A; Gaidano G; Gloghini A; Larocca LM; Capello D; Canzonieri V; Antinori A; Tirelli U; Falini B; Dalla-Favera R
Blood; 1998 Feb; 91(3):747-55. PubMed ID: 9446632
[TBL] [Abstract][Full Text] [Related]
6. Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen.
Gaidano G; Gloghini A; Gattei V; Rossi MF; Cilia AM; Godeas C; Degan M; Perin T; Canzonieri V; Aldinucci D; Saglio G; Carbone A; Pinto A
Blood; 1997 Dec; 90(12):4894-900. PubMed ID: 9389706
[TBL] [Abstract][Full Text] [Related]
7. [Syndecan-1 (CD138): an immunohistochemical marker of plasma cell tumors].
Fakan F; Boudová L; Hejda C
Cesk Patol; 2002 Jan; 38(1):33-6. PubMed ID: 11933459
[TBL] [Abstract][Full Text] [Related]
8. Characterization of anti-CD138 monoclonal antibodies as tools for investigating the molecular polymorphism of syndecan-1 in human lymphoma cells.
Gattei V; Godeas C; Degan M; Rossi FM; Aldinucci D; Pinto A
Br J Haematol; 1999 Jan; 104(1):152-62. PubMed ID: 10027728
[TBL] [Abstract][Full Text] [Related]
9. Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma.
Shah L; Walter KL; Borczuk AC; Kawut SM; Sonett JR; Gorenstein LA; Ginsburg ME; Steinglass KM; Powell CA
Cancer; 2004 Oct; 101(7):1632-8. PubMed ID: 15378500
[TBL] [Abstract][Full Text] [Related]
10. Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas.
Saqi A; Yun SS; Yu GH; Alexis D; Taub RN; Powell CA; Borczuk AC
Diagn Cytopathol; 2005 Aug; 33(2):65-70. PubMed ID: 16007640
[TBL] [Abstract][Full Text] [Related]
11. Can syndecan-1 become a prognostic factor in solid tumors?
Oguri K; Okayama M
J Gastroenterol; 2004; 39(2):197-9. PubMed ID: 15074308
[No Abstract] [Full Text] [Related]
12. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
[TBL] [Abstract][Full Text] [Related]
13. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms.
O'Connell FP; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2004 Feb; 121(2):254-63. PubMed ID: 14983940
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of soluble syndecan-1 in Hodgkin's lymphoma.
Vassilakopoulos TP; Kyrtsonis MC; Papadogiannis A; Nadali G; Angelopoulou MK; Tzenou T; Dimopoulou MN; Siakantaris MP; Kontopidou FN; Kalpadakis C; Kokoris SI; Dimitriadou EM; Tsaftaridis P; Pizzolo G; Pangalis GA
Anticancer Res; 2005; 25(6C):4743-6. PubMed ID: 16334170
[TBL] [Abstract][Full Text] [Related]
15. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis.
Carbone A; Gloghini A; Cozzi MR; Capello D; Steffan A; Monini P; De Marco L; Gaidano G
Br J Haematol; 2000 Oct; 111(1):247-57. PubMed ID: 11091208
[TBL] [Abstract][Full Text] [Related]
16. Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin.
Gallo R; Kim C; Kokenyesi R; Adzick NS; Bernfield M
J Invest Dermatol; 1996 Nov; 107(5):676-83. PubMed ID: 8875948
[TBL] [Abstract][Full Text] [Related]
17. Distribution of syndecans 1-4 within the anterior segment of the human eye: expression of a variant syndecan-3 and matrix-associated syndecan-2.
Filla MS; David G; Weinreb RN; Kaufman PL; Peters DM
Exp Eye Res; 2004 Jul; 79(1):61-74. PubMed ID: 15183101
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors.
Aref S; Goda T; El-Sherbiny M
Hematology; 2003 Aug; 8(4):221-8. PubMed ID: 12911939
[TBL] [Abstract][Full Text] [Related]
19. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases.
Coupland SE; Foss HD; Hidayat AA; Cockerham GC; Hummel M; Stein H
J Pathol; 2002 Jul; 197(3):333-40. PubMed ID: 12115879
[TBL] [Abstract][Full Text] [Related]
20. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage.
Cattoretti G; Angelin-Duclos C; Shaknovich R; Zhou H; Wang D; Alobeid B
J Pathol; 2005 May; 206(1):76-86. PubMed ID: 15772984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]